The renowned type-2-high immunity occurs in almost half of asthma patients, manifested as features of eosinophilia, AHR, the elevation of IL-4, IL-5, IL-13, and Ig E in lung and blood (Fahy, 2015; Lambrecht et al., 2019). This evidence concerns the gene IL4 and Increased total eosinophil count.